George N Liberis, MD, ScD, FACS is categorized under Doctors in New City, NY and active since 1985.
George N Liberis, MD, ScD, FACS was established in 1985, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number by the NAICS.
If you are seeking more information, feel free to contact Bette nussbaum at the company’s single location by writing to 180 Phillips Hill Road 2B, New City, NY 10956, New City, New York NY 10956 or by phoning (845) 354-8304. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | George N Liberis, MD, ScD, FACS |
| Contact Person: | Bette nussbaum |
| Address: | 180 Phillips Hill Road 2B, New City, NY 10956, New City, New York 10956 |
| Phone Number: | (845) 354-8304 |
| Website Address: | drliberis.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1985 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| Share This Business: |
George N Liberis, MD, ScD, FACS was started in 1985 to provide professional Doctors under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Bette nussbaum for inquiries that concern George N Liberis, MD, ScD, FACS by calling the company number (845) 354-8304, as your correspondence is most welcome. Additionally, the physical location of the single location of George N Liberis, MD, ScD, FACS can be found at the coordinates 41.1475954,-73.989306 as well as the street address 180 Phillips Hill Road 2B, New City, NY 10956 in New City, New York 10956.
For its online presence, you may visit George N Liberis, MD, ScD, FACS’s website at drliberis.com and engage with its social media outlets through on Twitter and on Facebook.